Hospital.Help

Zurich/Nashville – The time between the approval of a new drug and the decision whether the health insurance will pay for it is shorter in European countries than in the USA. This is reported by a Swiss-American working group in the Annals of Internal Medicine (2024; DOI: 10.7326/ANNALS-24-006). “While regulatory approval enables new drugs to enter the market, reimbursement by the…